Bernstein Harold bought MAZE
January 7, 2026 · Form 4 insider transaction
Bernstein Harold bought 25,156 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $262.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,156
Price
$10.42
Total value
$262.1K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after25,156
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.